This would lead to higher levels of immune activation and of CCR5 expression on CD4+ T-cells in utero, thereby increasing susceptibility to HIV infection in female fetuses, and, in particular, to the IFN-I-resistant viruses that would be the major circulating form of virus following recent maternal infection. This evidence concerns the gene CCR5 and HIV infectious disease.